These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 7000043)

  • 21. In vivo antiaggregatory action of platelet-activating factor in beagle dogs: role for prostacyclin.
    Hermán F; Magyar K; Filep JG
    Thromb Haemost; 1991 Mar; 65(3):296-9. PubMed ID: 2048053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An in vivo model for studying platelet aggregation and disaggregation.
    Page CP; Paul W; Morley J
    Thromb Haemost; 1982 Jun; 47(3):210-3. PubMed ID: 7051409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative effects of aspirin on platelet aggregation and prostaglandin-mediated coronary vasodilatation in the dog.
    Capurro NL; Lipson LC; Bonow RO; Goldstein RE; Shulman NR; Epstein SE
    Circulation; 1980 Dec; 62(6):1221-7. PubMed ID: 7438358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of the chronotropic effects of prostacyclin in the dog: comparison with the actions of prostaglandin E2.
    Chiba S; Malik KU
    J Pharmacol Exp Ther; 1980 May; 213(2):261-6. PubMed ID: 6988574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preservation of platelets and their function in prolonged cardiopulmonary bypass using prostacyclin.
    Koshal A; Krausz MM; Utsunomiya T; Hechtman HB; Collins JJ; Cohn LH
    Circulation; 1981 Aug; 64(2 Pt 2):II44-8. PubMed ID: 7018736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
    Smith JB; Araki H; Lefer AM
    Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet preservation during cardiopulmonary bypass (CPB) with prostaglandin (PGE1) and prostacyclin (PGI2).
    van den Dungen JJ; Velders AJ; Karliczek GF; Homan van der Heide JN; Wildevuur CR
    Trans Am Soc Artif Intern Organs; 1980; 26():481-6. PubMed ID: 7018057
    [No Abstract]   [Full Text] [Related]  

  • 28. Antithrombotic and vasodilating effects of OP-41483, a prostacyclin derivative.
    Kinjo O; Kusaba A; Uesato T; Shiroma H; Koja K; Kina M; Kuniyoshi Y; Iha K; Shiohira T; Kawabata T
    Int Angiol; 1987; 6(3):279-85. PubMed ID: 3329206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissociation between hemodynamic and platelet antiaggregant effects of prostacyclin in dogs determined with a rapid platelet isolation technique.
    Czer GT; Moser KM
    J Lab Clin Med; 1983 Jul; 102(1):133-9. PubMed ID: 6343535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cardiovascular and platelet actions of 9 beta-methyl carbacyclin (ciprostene), a chemically stable analogue of prostacyclin, in the dog and monkey.
    Allan G; Follenfant MJ; Lidbury P; Oliver PL; Whittle BJ
    Br J Pharmacol; 1985 Jun; 85(2):547-55. PubMed ID: 3896365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation.
    Cook JJ; Sitko GR; Holahan MA; Stranieri MT; Glass JD; Askew BC; McIntyre CJ; Claremon DA; Baldwin JJ; Hartman GD; Gould RJ; Lynch JJ
    J Pharmacol Exp Ther; 1997 May; 281(2):677-89. PubMed ID: 9152373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbacyclin--a potent stable prostacyclin analogue for the inhibition of platelet aggregation.
    Whittle BJ; Moncada S; Whiting F; Vane JR
    Prostaglandins; 1980 Apr; 19(4):605-27. PubMed ID: 6992234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of PGI2, CH-7284 and CH-7384 on spontaneous platelet aggregation and blood pressure of anaesthetized beagles.
    Hermán F; Malomvölgyi B; Hadházy P; Magyar K
    Biomed Biochim Acta; 1988; 47(10-11):S113-6. PubMed ID: 3073758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo antiaggregatory effect of BM 13.177 on the spontaneous platelet aggregation in anaesthetized beagle dogs.
    Hermán F; Malomvölgyi B; Hadházy P; Magyar K
    Biomed Biochim Acta; 1988; 47(10-11):S90-3. PubMed ID: 3073773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of platelet aggregation with intravenous and oral administration of carboprostacyclin in man.
    Karim SM; Adaikan PG; Lau LC; Tai MY
    Prostaglandins Med; 1981 May; 6(5):521-7. PubMed ID: 7022510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
    Eggerman TL; Harker LA; Andersen NH; Wilson CH
    Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experimental studies on platelet preservation with prostaglandin I2 and its derivative (OP-41483) during cardiopulmonary bypass].
    Takeda H
    Hokkaido Igaku Zasshi; 1989 Jul; 64(4):500-11. PubMed ID: 2511131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacology of prostacyclin].
    Imai S
    Kokyu To Junkan; 1985 Jul; 33(7):845-9. PubMed ID: 2997894
    [No Abstract]   [Full Text] [Related]  

  • 39. Cardiovascular and electrophysiological analysis of a selective vasodilatory prostacyclin analogue, 5-nitro-PGI1.
    Kecskeméti V; Stadler I; Körmöczy P
    Biomed Biochim Acta; 1984; 43(8-9):S287-90. PubMed ID: 6440542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous administration of prostacyclin in rabbits: elimination kinetics and blood pressure response.
    Skrinska VA; Lucas FV; Chisolm GM; Hesse BL
    J Lab Clin Med; 1986 Mar; 107(3):187-93. PubMed ID: 3512745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.